DOI: 10.1055/s-00000125

Senologie - Zeitschrift für Mammadiagnostik und -therapie

References

Robert NJ, Diéras V, Glaspy J. et al.
RIBBON-1: Randomized, Double-Blind, Placebo-Controlled, Phase III Trial of Chemotherapy With or Without Bevacizumab for First-Line Treatment of Human Epidermal Growth Factor Receptor 2-negative, Locally Recurrent or Metastatic Breast Cancer.

J Clin Oncol 2011;
29: 1252-1260

Download Bibliographical Data

Access:
Access: